Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials MV Maraldo, F Giusti, IR Vogelius, M Lundemann, MAE van der Kaaij, ... The Lancet Haematology 2 (11), e492-e502, 2015 | 149 | 2015 |
Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both? MC Aznar, MV Maraldo, DA Schut, M Lundemann, NP Brodin, IR Vogelius, ... International Journal of Radiation Oncology* Biology* Physics 92 (1), 169-174, 2015 | 134 | 2015 |
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma SH Poulsen, T Urup, K Grunnet, IJ Christensen, VA Larsen, ML Jensen, ... European journal of nuclear medicine and molecular imaging 44, 373-381, 2017 | 71 | 2017 |
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma P Munck af Rosenschold, J Costa, SA Engelholm, MJ Lundemann, I Law, ... Neuro-oncology 17 (5), 757-763, 2015 | 62 | 2015 |
Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma M Lundemann, P Munck af Rosenschöld, A Muhic, VA Larsen, ... European journal of nuclear medicine and molecular imaging 46, 603-613, 2019 | 56 | 2019 |
Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective L Marner, OM Henriksen, M Lundemann, VA Larsen, I Law Clinical and translational imaging 5, 135-149, 2017 | 54 | 2017 |
A modality-adaptive method for segmenting brain tumors and organs-at-risk in radiation therapy planning M Agn, PM af Rosenschöld, O Puonti, MJ Lundemann, L Mancini, ... Medical image analysis 54, 220-237, 2019 | 46 | 2019 |
Early postoperative 18F-FET PET/MRI for pediatric brain and spinal cord tumors L Marner, K Nysom, A Sehested, L Borgwardt, R Mathiasen, ... Journal of Nuclear Medicine 60 (8), 1053-1058, 2019 | 34 | 2019 |
Patterns of failure for patients with glioblastoma following O-(2-[18F] fluoroethyl)-L-tyrosine PET-and MRI-guided radiotherapy M Lundemann, JC Costa, I Law, SA Engelholm, A Muhic, HS Poulsen, ... Radiotherapy and Oncology 122 (3), 380-386, 2017 | 33 | 2017 |
Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study MM Clausen, AE Hansen, M Lundemann, C Hollensen, T Pommer, ... Radiation Oncology 9, 1-8, 2014 | 23 | 2014 |
Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors L Marner, M Lundemann, A Sehested, K Nysom, L Borgwardt, ... Neuro-oncology 23 (12), 2107-2116, 2021 | 20 | 2021 |
A new method to estimate doses to the normal tissues after past extended and involved field radiotherapy for Hodgkin lymphoma MV Maraldo, M Lundemann, IR Vogelius, L Specht Radiotherapy and Oncology 114 (2), 206-211, 2015 | 20 | 2015 |
European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group. Cardiovascular disease after treatment for Hodgkin’s lymphoma: an analysis of nine … MV Maraldo, F Giusti, IR Vogelius, M Lundemann, MA van der Kaaij, ... Lancet Haematol 2 (11), e492-e502, 2015 | 19 | 2015 |
Munck Af Rosenschöld P, Muhic A, Larsen VA, Poulsen HS, Engelholm SA, et al. Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with … M Lundemann Eur J Nucl Med Mol Imaging 46 (3), 603-13, 2019 | 16 | 2019 |
A framework for voxel‐based assessment of biological effect after proton radiotherapy in pediatric brain cancer patients using multi‐modal imaging M Skaarup, MJ Lundemann, S Darkner, M Jørgensen, L Marner, ... Medical physics 48 (7), 4110-4121, 2021 | 15 | 2021 |
External validation of an artificial intelligence tool for radiographic knee osteoarthritis severity classification MW Brejnebøl, P Hansen, JU Nybing, R Bachmann, U Ratjen, IV Hansen, ... European Journal of Radiology 150, 110249, 2022 | 14 | 2022 |
A deep learning algorithm for Radiographic measurements of the hip in Adults—A reliability and agreement study J Jensen, O Graumann, S Overgaard, O Gerke, M Lundemann, ... Diagnostics 12 (11), 2597, 2022 | 12 | 2022 |
Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients PM af Rosenschold, I Law, S Engelholm, SA Engelholm, A Muhic, ... Radiotherapy and Oncology 130, 149-155, 2019 | 10 | 2019 |
Early changes in perfusion of glioblastoma during radio-and chemotherapy evaluated by T1-dynamic contrast enhanced magnetic resonance imaging S Møller, M Lundemann, I Law, HS Poulsen, HBW Larsson, ... Acta Oncologica 54 (9), 1521-1528, 2015 | 10 | 2015 |
Cardiovascular disease after treatment for Hodgkin’s lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematol 2015; 2: e492–502 MV Maraldo, F Giusti, IR Vogelius, M Lundemann, MAE Van der Kaaij, ... | 9 | |